---
title: "BCL11B"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Gene: BCL11B"
tags: ['BCL11B', 'TranscriptionFactor', 'NeuralDevelopment', 'Immunodeficiency', 'IntellectualDisability', 'MissenseMutation', 'FrameshiftMutation', 'Prognosis']
---

# Gene: BCL11B

## Basic Information
- Function for gene: Transcription factor involved in neural development, immune cell differentiation, and oncogenesis
- External IDs for gene and genomic location, Aliases:
    - HGNC: 985
    - NCBI Entrez: 64919
    - Ensembl: ENSG00000144455
    - OMIM: 606557
    - UniProtKB/Swiss-Prot: Q9C0K0
    - Genomic location: Chromosome 14q32.2

## Mutations
- AA mutation list and mutation type with dbSNP ID:
    - p.Ala168Val (missense) - rs774215653
    - p.Asp336His (missense) - rs367543139
    - p.Gly360Val (missense) - rs375466717
    - p.Arg382Trp (missense) - rs267607265
- Somatic SNVs/InDels with dbSNP ID:
    - c.559G>T (missense) - rs200849510
    - c.1018G>A (missense) - rs775787337
    - c.1009_1012delGAAG (frameshift) - rs767989824

## Related Diseases
- Intellectual disability, autosomal dominant 48 (OMIM #617787)
- Immunodeficiency 43 (OMIM #241600)

## Treatment and Prognosis
- Currently, there is no specific treatment for BCL11B-related diseases
- Prognosis varies depending on the specific disease and severity of symptoms

## Drug Response
- No known drug response at this time.

## References 
- Subject: "BCL11B" 
- Author: B Wright 
- DOI links to related papers: 
    - [Genetic and epigenetic dissection of the cohesin chromatin looping complex in human neurodevelopmental disease]([Click](https://pubmed.ncbi.nlm.nih.gov/30559479/))
    - [BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells]([Click](https://pubmed.ncbi.nlm.nih.gov/32376400/))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**